Rankings
▼
Calendar
ARQT Q4 2025 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$130M
+81.5% YoY
Gross Profit
$118M
91.0% margin
Operating Income
$18M
14.2% margin
Net Income
$17M
13.4% margin
EPS (Diluted)
$0.13
QoQ Revenue Growth
+30.5%
Cash Flow
Operating Cash Flow
$26M
Free Cash Flow
$26M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$433M
Total Liabilities
$243M
Stockholders' Equity
$189M
Cash & Equivalents
$43M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$130M
$71M
+81.5%
Gross Profit
$118M
$64M
+82.8%
Operating Income
$18M
-$8M
+340.9%
Net Income
$17M
-$11M
+261.2%
← FY 2025
All Quarters